Caricamento...
Ruxolitinib for Myelofibrosis – An Update of Its Clinical Effects
Myelofibrosis (MF), associated with a Philadelphia chromosome-negative myeloproliferative neoplasms, is characterized by progressive bone marrow fibrosis and ineffective hematopoiesis. Clinical hallmarks include splenomegaly, anemia, and debilitating symptoms. In two randomized phase III studies, th...
Salvato in:
| Pubblicato in: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5556922/ https://ncbi.nlm.nih.gov/pubmed/24238036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2013.09.006 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|